Tubacin CAS: 537049-40-4

CAS NO: 537049-40-4
Tubacin
Chemical Name: Tubacin
Molecular Formula: C41H43N3O7S
Formula Weight: 721.86
CAS No.: 537049-40-4
Description Review
Description

Tubacin is a small molecule inhibitor of histone deacetylase 6 (HDAC6), an enzyme involved in the regulation of cellular processes such as protein degradation and cell motility. This product is a white powder with the chemical formula C22H24N2O3S and a molecular weight of 408.5 g/mol. Its CAS number is 537049-40-4.

Top ten keywords from Google and Synonyms

  1. Tubacin
  2. HDAC6 inhibitor
  3. Cancer therapy
  4. Neuroprotection
  5. Protein degradation
  6. Cell motility
  7. Anti-inflammatory effects
  8. Epigenetics
  9. Autophagy
  10. Gene expression

Synonyms:

  • N-(4-tert-butylphenyl)-N-hydroxy-4-(2-phenylethyl)benzamide

Health benefits of Tubacin

Tubacin has shown potential health benefits in various areas such as cancer therapy, neuroprotection, and anti-inflammatory effects.

Cancer Therapy: Tubacin has been reported to have potent anti-tumor effects in various types of cancers such as breast cancer and leukemia. The mechanism behind its efficacy is due to its ability to inhibit HDAC6, which plays a critical role in the regulation of gene expression and cellular processes such as protein degradation and autophagy. By inhibiting this process, Tubacin can suppress the growth and proliferation of cancer cells.

Neuroprotection: Tubacin has also demonstrated neuroprotective effects in various models of neurological disorders such as Huntington's disease and Alzheimer's disease. These effects are associated with its ability to stimulate autophagy, a process by which damaged proteins and organelles are eliminated, thus preventing their accumulation and toxicity.

Anti-inflammatory Effects: Tubacin has been shown to have anti-inflammatory effects in various models of inflammation such as arthritis and asthma. These effects are associated with its ability to inhibit HDAC6, which regulates the activity of pro-inflammatory genes.

Potential Effects

Tubacin has shown promise as an anti-tumor agent in cancer therapy, as well as neuroprotective and anti-inflammatory effects. Its potential role in epigenetic regulation suggests it may also have applications in epigenetic therapy.

Product Mechanism

Tubacin inhibits HDAC6, which plays a critical role in the regulation of gene expression and cellular processes such as protein degradation and autophagy. By inhibiting this process, Tubacin can suppress the growth and proliferation of cancer cells, stimulate autophagy, and regulate the activity of pro-inflammatory genes. These effects suggest that Tubacin may have potential as an epigenetic therapy.

Safety

While Tubacin has shown promising results in preclinical studies, further investigation into its safety in humans is required. Animal studies have not shown significant adverse effects, but more research is needed to fully understand its safety profile.

Side Effects

Currently, there is limited information regarding the side effects of Tubacin. However, caution should be taken, and patients should consult with their healthcare provider before use.

Dosing Information

Dosing information for Tubacin is not yet established. Further study is necessary to determine safe and effective dosing guidelines.

Conclusion

Tubacin has shown significant potential as a therapeutic agent in various fields of medicine, particularly in cancer therapy, neuroprotection, and anti-inflammatory effects. Its ability to inhibit HDAC6 provides a novel approach to regulating gene expression and cellular processes such as protein degradation and autophagy. While more research is needed to establish safety and dosing guidelines for human use, Tubacin shows promise as a potential treatment option. Its ability to inhibit HDAC6 suggests that it may play an important role in future cancer treatments and as a neuroprotective and anti-inflammatory agent

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us